摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-dipentylthiourea | 31182-23-7

中文名称
——
中文别名
——
英文名称
N,N'-dipentylthiourea
英文别名
1,3-dipentyl-thiourea;1,3-dipentylthiourea
N,N'-dipentylthiourea化学式
CAS
31182-23-7
化学式
C11H24N2S
mdl
——
分子量
216.391
InChiKey
IFFMDHHTDSTHBZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    56-58 °C
  • 沸点:
    288.0±23.0 °C(Predicted)
  • 密度:
    0.929±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    14
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    56.2
  • 氢给体数:
    2
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    N,N'-dipentylthiourea丁炔二酸 生成 [3-pentyl-2-(pentylimino)-4-oxo-5-thiazolidinylidene]acetic acid
    参考文献:
    名称:
    [3-substituted-2-(substituted imino)-4-oxo-5-thiazolidinylidene]acetic
    摘要:
    本发明提供了新颖的[3-取代-2-(取代亚胺)-4-氧代-5-噻唑烯基]乙酸,以及新颖的药物组合物和使用方法。该发明的新颖酸是白三烯拮抗剂,具有用于治疗哮喘、过敏、心血管疾病、偏头痛和炎症的活性。
    公开号:
    US04775677A1
  • 作为产物:
    描述:
    二硫化碳1-氨基戊烷aluminum oxidezinc(II) oxide 作用下, 反应 2.0h, 以95%的产率得到N,N'-dipentylthiourea
    参考文献:
    名称:
    Synthesis of Symmetrical N,N-Disubstituted Thioureas and Heterocyclic Thiones from Amines and CS2 over a ZnO/Al2O3 Composite as Heterogeneous and Reusable Catalyst
    摘要:
    DOI:
    10.1021/jo981629b
点击查看最新优质反应信息

文献信息

  • CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS - ANDROGEN RECEPTOR ANTAGONISTS, ANTICANCER AGENT, METHOD FOR PREPARATION AND USE THEREOF
    申请人:Ivachtchenko Alexandre Vasilievich
    公开号:US20130116269A1
    公开(公告)日:2013-05-09
    The present invention relates to novel cyclic N,N′-diarylureas and N,N′-diarylthioureas—androgen receptor antagonists, anti-cancer agent, pharmaceutical composition, medicament, and method for treatment of cancerous diseases, among them prostate cancer. Cyclic N,N′-diarylthioureas or N,N′-diarylureas of the general formula 1, their optical (R)- and (S)-isomers and pharmaceutically acceptable salts thereof exhibiting properties of androgen receptor antagonists have been proposed, wherein: X represents oxygen or sulfur; m=0 or 1; R1 represents C 1 -C 3 alkyl; R2 and R3 represent hydrogen; or R2 and R3 together with C-atom they are attached to form C═O group; R4 and R5 represent hydrogen; or R4 represents hydrogen, R5 represents methyl; or R4 represents methyl, R5 represents CH 2 R6 group in which R6 represents C 1 -C 3 alkoxycarbonyl, carboxyl, hydroxyl group optionally substituted with methyl or benzyl; or R4 and R5 together with C-atom they are attached to form 5- or 6-membered heterocycle comprising at least one oxygen atom or nitrogen atom optionally substituted with methyl; or R4 and R5 together with C-atom they are attached to form NH group.
    本发明涉及新颖的环状N,N′-二芳基脲和N,N′-二芳基硫脲—雄激素受体拮抗剂、抗癌剂、药物组合物、药物以及治疗癌症性疾病的方法,其中包括前列腺癌。已经提出了一般式1的环状N,N′-二芳基硫脲或N,N′-二芳基脲,它们的光学异构体(R)-和(S)-以及其药用盐具有雄激素受体拮抗剂的性质,其中:X代表氧或硫;m=0或1;R1代表C1-C3烷基;R2和R3代表氢;或R2和R3与它们连接的C原子一起形成C═O基团;R4和R5代表氢;或R4代表氢,R5代表甲基;或R4代表甲基,R5代表CH2R6基团,其中R6代表C1-C3烷氧羰基、羧基、羟基,可选择地被甲基或苄基取代;或R4和R5与C原子一起形成至少含有一个氧原子或氮原子的5-或6元杂环;或R4和R5与C原子一起形成NH基团。
  • Studies on 1,2,4-Thiadiazolidine Derivatives. I. The Synthesis and Structural Determination of 2,4-Disubstituted 3,5-Disubstituted Imino-1,2,4-thiadiazolidines
    作者:Takeshi Kinoshita、Sadao Sato、Chihiro Tamura
    DOI:10.1246/bcsj.49.2236
    日期:1976.8
    The reaction of symmetrical thiourea derivatives, RNHCSNHR, with benzoyl peroxide (BPO) gave only one isomer of 2,4-disubstituted 3,5-disubstituted imino-1,2,4-thiadiazolidines, and that of nonsymmetrical thiourea derivatives, RNHCSNHR′, with BPO yielded a mixture of some of the possible isomeric derivatives. The structures of these compounds were determined by means of NMR, mass spectra, and X-ray
    对称硫脲衍生物 RNHCSNHR 与过氧化苯甲酰 (BPO) 的反应仅产生 2,4-二取代 3,5-二取代亚氨基-1,2,4-噻二唑烷的一种异构体,以及非对称硫脲衍生物 RNHCSNHR' 的异构体,与 BPO 产生一些可能的异构衍生物的混合物。这些化合物的结构是通过核磁共振、质谱和 X 射线分析确定的。讨论了噻二唑烷环周围基团的空间效应和一些反应机理。
  • FUNCTIONALIZED HIGHLY BRANCHED MELAMINE-POLYAMINE POLYMERS
    申请人:Peretolchin Maxim
    公开号:US20120252987A1
    公开(公告)日:2012-10-04
    The present invention relates to a method for producing amphiphilic functionalized highly branched melamine-polyamine polymers by condensing melamine and optionally a melamine derivate having at least one different amine having at least two primary amino groups and optionally also with urea and/or at least one urea derivative and/or with at least one at least difunctional diisocyanate or polyisocyanate and/or at least one carbolic acid having at least two carboxyl groups or at least one derivative thereof, optionally quaternizing a portion of the amino groups of the polymer thereby obtained, reacting the polymer thus obtained with at least one compound capable of undergoing a condensation or addition reaction with amino groups, and optionally quaternizing at least part of the amino groups of the polymer obtained in the first step. The invention further relates to the amphiphilic functionalized highly branched melamine-polyamine polymers that can be obtained by the method according to the invention, and to the use thereof as surface active agents.
    本发明涉及一种通过将三聚氰胺和至少一种具有至少两个主要氨基的不同氨基的三聚氰胺衍生物以及可能还包括尿素和/或至少一种尿素衍生物和/或至少一种至少双官能团二异氰酸酯或多异氰酸酯和/或至少一种至少具有两个羧基的羧酸或其衍生物缩合,从而制备含有两性功能化的高支化三聚氰胺-多胺聚合物的方法。可选地,对所获得的聚合物的部分氨基进行季铵化,然后将所获得的聚合物与至少一种能够与氨基发生缩合或加成反应的化合物反应,并可选地对第一步中获得的聚合物的部分氨基进行季铵化。本发明还涉及通过本发明的方法可以获得的含有两性功能化的高支化三聚氰胺-多胺聚合物,以及将其用作表面活性剂的用途。
  • [EN] CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS AS ANDROGEN RECEPTOR ANTAGONISTS, ANTI-CANCER AGENT, METHOD FOR PRODUCING AND USING SAME<br/>[FR] N,N'-DIARYLURÉES ET N,N'-DIARYLTHIOURÉES CYCLIQUES, ANTAGONISTES DE RÉCEPTEURS D'ANDROGÈNES, AGENT ANTI-CANCER ET PROCÉDÉ DE PRODUCTION ET D'APPLICATION
    申请人:IVACHTCHENKO ALEXANDRE VASILIEVICH
    公开号:WO2012011840A1
    公开(公告)日:2012-01-26
    Настоящее изобретение относится к новым циклическим Ν,Ν'-диарилмочевинам и Ν,Ν'-диарилтиомочевинам - антагонистам андрогеновых рецепторов, противораковому средству, фармацевтической композиции, лекарственному средству и способу лечения раковых заболеваний, в том числе рака простаты. Предложены циклические Ν,Ν'-диарилтиомочевины или Ν,Ν'-диарилмочевины общей формулы 1, их оптические (R)- и (S)- изомеры и их фармацевтически приемлемые соли, обладающие свойствами антагонистов андрогеновых рецепторов, 1, где: X представляет собой кислород или серу; m = 0 или 1; R1 представляет собой C1-С3алкил; R2 и R3 представляют собой водород; или R2 и R3 вместе с атомом углерода, с которым они связаны, образуют группу С = О; R4 и R5 представляют собой водород; или R4 представляет собой водород, a R5 представляет собой метил; или R4 представляет собой метил, R5 представляет собой CH2R6 группу, в которой R6 представляет собой C1-C3 алкоксикарбонил, карбоксил, необязательно замещенную гидроксильную группу, в которой заместители могут быть водород, метил, бензил; или R4 и R5 вместе с атомом углерода, с которым они связаны, образуют пяти или шестичленный насыщенный гетероцикл, включающий, по крайней мере, один атом кислорода или азота, который может быть замещен метилом, или R4 и R5 вместе с атомом углерода, с которым они связаны, представляют собой группу NH.
    本发明涉及新的环状Ν,Ν'-二芳基尿素和Ν,Ν'-二芳基硫脲化合物 - 雄激素受体拮抗剂,抗癌药物,制药组合物,药物和治疗癌症的方法,包括前列腺癌。提供了通式1的环状Ν,Ν'-二芳基硫脲或Ν,Ν'-二芳基尿素,它们的光学异构体(R)和(S)以及它们的药物可接受盐,具有雄激素受体拮抗剂的性质,其中:X代表氧或硫;m = 0或1;R1代表C1-C3烷基;R2和R3代表氢;或R2和R3与它们连接的碳原子一起形成C = O基团;R4和R5代表氢;或R4代表氢,R5代表甲基;或R4代表甲基,R5代表CH2R6基团,其中R6代表C1-C3烷氧羰基,羧基,可选地取代的羟基,其中取代基可以是氢,甲基,苯甲基;或R4和R5与它们连接的碳原子一起形成五元或六元饱和杂环,包括至少一个氧或氮原子,该原子可以被甲基取代,或R4和R5与它们连接的碳原子形成NH基团。
  • N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION
    申请人:Aktas Bertal Huseyin
    公开号:US20120115915A1
    公开(公告)日:2012-05-10
    Compositions and methods for inhibiting translation initiation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using N,N′-diarylureas and/or N,N′-diarylthiourea compounds are described.
    本文提供了抑制翻译起始的组合物和方法。描述了使用N,N'-二芳基脲和/或N,N'-二芳基硫脲化合物治疗(1)细胞增生性疾病,(2)非增生性退行性疾病,(3)病毒感染和/或(4)与病毒感染相关的疾病的组合物、方法和试剂盒。
查看更多